Treatment of hypertrophic obstructive cardiomyopathy with alcohol ablation Kulić M., Spužić M., Tahirović E., Mujačić V., Šošević A., Perva O., Ćibo M.,

Slides:



Advertisements
Similar presentations
Kulić M., Mujičić E., Šošević A., Gorani D.*, Tahirović E., Spužić M.
Advertisements

Advance Heart Failure Therapy
Emergency/Urgent Referral* (3) -Pt acutely unwell with palpitations -Pt with haemodyanically unstable acute onset AF -2 nd /3 rd heart block -Exercise.
Hypertrophic Cardiomyopathy
Atrial fibrillation Cardiology #2 Gimadeeva A.D..
Patients with suspected syncope should be investigated by cardiologists Dr NR Stout.
Hypertrophic Cardiomyopathy Guidelines Summary from the: ACC/ESC Clinical Expert Consensus Statement on Hypertrophic Cardiomyopathy Maron BJ, et al. J.
Cardiomyopathies Dr. Hesham K. Rashid, MD Ass. Professor of Cardiology Benha University.
1 Heart Failure William Chavey, MD, MS Associate Professor Department of Family Medicine University of Michigan.
Atrial Fibrillation Update 2012 Dr C Seifer Section of Cardiology St Boniface Hospital.
Primary Myocardial Disease Dr. Raid Jastania. Case.
Congestive Heart Failure Stephen Gottlieb, MD Professor of Medicine Director, Cardiomyopathy and Pulmonary Hypertension University of Maryland.
 Genetic disease of heart muscle characterized by left ventricular hypertrophy in absence of another cardiac or systemic disease; variable morphologies.
DR. HANA OMER CONGENITAL HEART DEFECTS. The major development of the fetal heart occurs between the fourth and seventh weeks of gestation, and most congenital.
Cardiac Issues in Friedreich’s Ataxia 2 nd Annual Friedreich’s Ataxia Symposium Robert E. Shaddy, MD Jennifer Terker Professor of Pediatrics Division Chief,
Dr. Meg-angela Christi M. Amores
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Hypertrophic Cardiomyopathy
Duchenne Muscular Dystrophy: Cardiac Management. Introduction Aim: early detection and treatment of deterioration in heart muscle function Cardiac disease.
Inflammatory and Structural Heart Disorders Valvular Heart Disease
Principles of diagnsosis of ischemic heart disease Mohammad Hashemi Interventional cardiologist Department of cardiology.
Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.
Sudden Cardiac Death; Invasive Evaluation Alpay Çeliker MD Hacettepe University Department of Pediatric Cardiology Ankara, Türkiye.
First author: Sendrea Octavian-Laurentiu Coordinator: Senior Lecturer Gozar Liliana, MD, PhD.
CPC Hypertrophic Cardiomyopathy. FACTS of INTEREST Patient was relatively asymptomatic until follow-up visit at WRAMC. Both his mother and older sibling.
Prof. N. Sudhaya Kumar, AIMS, Cochin. Primary cardiomyopathies Genetic HCM ARVD LV noncompaction Mitochondral myopathy Glyc.storage dis. channelopathies.
Cardiology ABIM Review. MKSAP Topics Nelle –Coronary artery disease –Valvular heart disease –Pregnancy –Peripheral arterial disease Dylan –Arrhythmias.
Septal ablation in Hypertrophic Cardiomyopathy Charles Knight London Chest Hospital Advanced Angioplasty 2003.
Abnormalities of the Conduction System Elizabeth Dugan - Olamide Odubogun -
Percutaneous Septal Myocardial Ablation (PASMA) Cardiovascular Institute & Fu Wai Hospital Chinese Academy of Medical Science You Shi Jie MD
Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Results from the Euro-ASA registry Veselka J, Jensen.
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Cardiovascular Blueprint PANCE Blueprint. Dilated Cardiomyopathy Defined as being characterized by enlargement of chambers and impaired systolic function.
CONGENITAL HEART DEFECTS DR. HANA OMER. CONGENITAL HEART DEFECTS D. HANA OMER.
Valvular Heart Disease
In the name of GOD 1. Treatment of End Stage Heart Failure Surgical Treatments Cardiac Resynchronization Treatment(CRT) 2.
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
Myocarditis and cardiomyopathies Noncoronary myocardial diseases.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy in Patients With Pre-Existing Cardiomyopathies.
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Contemporary Natural History and Management of Nonobstructive.
Mechanisms and Treatment of Symptoms in Hypertrophic Cardiomyopathy: Septal Reduction Therapy or Nothing? Andrew Wang, MD, FACC, FAHA Associate Professor.
Cardiomyopathies Pavol Tomašov.
Ethical Scenario: Cardiovascular System
Myocarditis Acute inflammatory condition that can have an infectious, toxic or autoimmune etiology. Viral infections are the most common causes, such as.
Ventricular Septal Defect Double Chamber RV (DCRV)
Sports and cardiology: an explosive cocktail?
Disclosures None.
Two-dimensional echocardiogram from a patient with severe hypertrophic cardiomyopathy. There is a severe increase in left ventricular wall thickness, with.
Structural Heart Live Cases
Cardiothoracic Surgery
Right ventricular disarticulation for arrythmogenic right ventricular dysplasia: an 18 year single centre experience. J Zacharias, J Forty, C Doig*, J.
Obstructive Hypertrophic Cardiomyopathy
Atrial Fibrillation: When Should You Consider Ablation?
By: Mahmoud Negm, Assistant lecturer
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Hypertrophic Cardiomyopathy
HYPERTROPHIC CARDIOMYOPATHY(HCM)
LVH & Heart murmur Murmur Increased w/ standing
New Developments in Hypertrophic Cardiomyopathy
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection  Derek V. Exner, MD, MPH, David.
Cardiology Consult Update
Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored … Until Now  Barry J. Maron, MD, Ethan J.
Cath-Lab Hemodynamics – I : Pressure tracings in the diseased heart
Mariette H. Schönbeck, Hans P. Brunner-La Rocca, Paul R. Vogt, Mario L
Surgical relief of left ventricular outflow obstruction in pediatric hypertrophic cardiomyopathy: The need for a tailored approach  John M. Karamichalis,
Jeffrey B. Geske et al. JCHF 2018;j.jchf
LVH & Heart murmur Murmur Increased w/ standing
Upper panel, representative volume rendering and multiplanar reconstruction image of MDCT showing left atrium before PTSMA. LA volume is shown. Upper panel,
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Bland-Altman analyses between cardiac MDCT and echocardiographic measurements of the index of maximum left atrial volume before (A) and after (B) PTSMA.
Presentation transcript:

Treatment of hypertrophic obstructive cardiomyopathy with alcohol ablation Kulić M., Spužić M., Tahirović E., Mujačić V., Šošević A., Perva O., Ćibo M., Zorman D.* Centar za srce, KCU Sarajevo *Univerzitetni klinični center Ljubljana V Congress of Cardiologists BiH with international participation, Radon Plaza, Sarajevo, may, 2010.

Def. Hypertrophic obstructive cardiomyopathy – primary genetic cardiac disorder, characterized with massive myocardial hypertrophy, with dynamic left ventricular outflow tract obstruction and diastolic dysfunction of the left ventricle. Kulić M, Spužić M, Tahirović E et al. Treatment of HOCM with alcohol ablation

Symptoms:  Angina,  Dyspnea,  Syncope,  Uncomfortable awareness of the heart beat (palpitations). Kulić M, Spužić M, Tahirović E et al. Treatment of HOCM with alcohol ablation

Treatment:  Medicamention;  Surgical myectomy;  Ventricular pacing;  Alcohol septal ablation – PTSMA* (Sigwart method) *PTSMA - percutaneous transluminal septal myocardial ablation Kulić M, Spužić M, Tahirović E et al. Treatment of HOCM with alcohol ablation

Nishimura R. and Holmes D. NEJM :1320 Kulić M, Spužić M, Tahirović E et al. Treatment of HOCM with alcohol ablation

Table 1. Characteristics of patients before PTSMA

Kulić M, Spužić M, Tahirović E et al. Treatment of HOCM with alcohol ablation

 Female patient 33 years old,  She was taken to Neurological Clinic because of syncope and family history of epilepsy. and family history of epilepsy.  After few weeks of treatment with antiepileptic, she had again dyspnea, syncopes and NYHA IV. she had again dyspnea, syncopes and NYHA IV.  ECHO IVSs 28mm, LVPWs 22mm, SAM, LVOTPG max 85mmHG, MR moderate, TRPGmax LVOTPG max 85mmHG, MR moderate, TRPGmax 35mmHg. 35mmHg.  ECG – HLV, without of heart rhythm disorders. Kulić M, Spužić M, Tahirović E et al. Treatment of HOCM with alcohol ablation CASE REPORT

 Started medication therapy (high doses of Beta-blockers – metoprolol) – unsuccessful !  Surgical myectomy – (Morrow method), four years after surgical myectomy without symptoms!  After four years again same symptoms like as dyspnea angina, syncope episodes.  ECHO IVSd 26mm (on the place surgical myectomy), LVOTPG mean 49mmHg, SAM, MR moderate.  Alcohol septal ablation – (Sigwart method). Kulić M, Spužić M, Tahirović E et al. Treatment of HOCM with alcohol ablation

HEMOD Y NAMIC DATA

PTSMA video Kulić M, Spužić M, Tahirović E et al. Treatment of HOCM with alcohol ablation

Conclusions  Invasive cardiology method,  Provides symptomatic relief,  Leads to hemodynamic improvement,  Refractory on medication therapy,  Unsuccessful surgical myectomy.

Thank you for your attention, Greetings from ” Department of Invasive Cardiology - Heart centre Sarajevo”!